| 000 | 01694 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518035323.0 | ||
| 264 | 0 | _c20200115 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0215219 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaharani, Asri | |
| 245 | 0 | 0 |
_aCardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study. _h[electronic resource] |
| 260 |
_bPloS one _c2019 |
||
| 300 |
_ae0215219 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAtherosclerosis _xepidemiology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aCoronary Disease _xepidemiology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aIndonesia _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aRural Population |
| 650 | 0 | 4 |
_aStroke _xepidemiology |
| 650 | 0 | 4 | _aUrban Population |
| 700 | 1 | _aPraveen, Devarsetty | |
| 700 | 1 | _aOceandy, Delvac | |
| 700 | 1 | _aTampubolon, Gindo | |
| 700 | 1 | _aPatel, Anushka | |
| 773 | 0 |
_tPloS one _gvol. 14 _gno. 4 _gp. e0215219 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0215219 _zAvailable from publisher's website |
| 999 |
_c29641648 _d29641648 |
||